End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.56 CNY | -1.57% | -4.08% | +22.34% |
Apr. 29 | Kanghong Pharmaceutical's Unit Gets US FDA's Green Light to Test Macular Degeneration Drug | MT |
Apr. 29 | Kanghong Pharmaceutical's Unit Gets Nod to Trial Macular Degeneration Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+22.34% | 2.87B | |
+32.36% | 694B | |
+30.77% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.77% | 239B | |
+9.13% | 209B | |
-3.97% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- 002773 Stock
- News Chengdu Kanghong Pharmaceutical Group Co., Ltd
- Kanghong Pharmaceutical's Unit Gets US FDA's Green Light to Test Macular Degeneration Drug